These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


409 related items for PubMed ID: 29408613

  • 1. Eudragit® L100-coated mannosylated chitosan nanoparticles for oral protein vaccine delivery.
    Xu B, Zhang W, Chen Y, Xu Y, Wang B, Zong L.
    Int J Biol Macromol; 2018 Jul 01; 113():534-542. PubMed ID: 29408613
    [Abstract] [Full Text] [Related]

  • 2. Synthesis of Eudragit® L100-coated chitosan-based nanoparticles for oral enoxaparin delivery.
    Patriota YBG, Arruda IES, de Jesus Oliveira AC, de Oliveira TC, de Lemos Vasconcelos Silva E, Chaves LL, de Oliveira Silva Ribeiro F, da Silva DA, de La Roca Soares MF, Soares-Sobrinho JL.
    Int J Biol Macromol; 2021 Dec 15; 193(Pt A):450-456. PubMed ID: 34688680
    [Abstract] [Full Text] [Related]

  • 3. Alginic acid-coated chitosan nanoparticles loaded with legumain DNA vaccine: effect against breast cancer in mice.
    Liu Z, Lv D, Liu S, Gong J, Wang D, Xiong M, Chen X, Xiang R, Tan X.
    PLoS One; 2013 Dec 15; 8(4):e60190. PubMed ID: 23577091
    [Abstract] [Full Text] [Related]

  • 4. Mechanistic study of the adjuvant effect of biodegradable nanoparticles in mucosal vaccination.
    Slütter B, Plapied L, Fievez V, Sande MA, des Rieux A, Schneider YJ, Van Riet E, Jiskoot W, Préat V.
    J Control Release; 2009 Sep 01; 138(2):113-21. PubMed ID: 19445980
    [Abstract] [Full Text] [Related]

  • 5. Characteristics, Cryoprotection Evaluation and In Vitro Release of BSA-Loaded Chitosan Nanoparticles.
    Yan Q, Weng J, Wu X, Wang W, Yang Q, Guo F, Wu D, Song Y, Chen F, Yang G.
    Mar Drugs; 2020 Jun 15; 18(6):. PubMed ID: 32549252
    [Abstract] [Full Text] [Related]

  • 6. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
    Bagre AP, Jain K, Jain NK.
    Int J Pharm; 2013 Nov 01; 456(1):31-40. PubMed ID: 23994363
    [Abstract] [Full Text] [Related]

  • 7. pH-sensitive and mucoadhesive thiolated Eudragit-coated chitosan microspheres.
    Quan JS, Jiang HL, Kim EM, Jeong HJ, Choi YJ, Guo DD, Yoo MK, Lee HG, Cho CS.
    Int J Pharm; 2008 Jul 09; 359(1-2):205-10. PubMed ID: 18490120
    [Abstract] [Full Text] [Related]

  • 8. Acidified sucralfate encapsulated chitosan derivative nanoparticles as oral vaccine adjuvant delivery enhancing mucosal and systemic immunity.
    Zhao Z, Qiao S, Jin Z, Li H, Yu H, Zhang C, Yin TH, Zhao K.
    Int J Biol Macromol; 2024 Nov 09; 279(Pt 3):135424. PubMed ID: 39245128
    [Abstract] [Full Text] [Related]

  • 9. Chitosan nanoparticles encapsulated vesicular systems for oral immunization: preparation, in-vitro and in-vivo characterization.
    Jain S, Sharma RK, Vyas SP.
    J Pharm Pharmacol; 2006 Mar 09; 58(3):303-10. PubMed ID: 16536896
    [Abstract] [Full Text] [Related]

  • 10. Thiolated Eudragit nanoparticles for oral insulin delivery: preparation, characterization and in vivo evaluation.
    Zhang Y, Wu X, Meng L, Zhang Y, Ai R, Qi N, He H, Xu H, Tang X.
    Int J Pharm; 2012 Oct 15; 436(1-2):341-50. PubMed ID: 22766443
    [Abstract] [Full Text] [Related]

  • 11. Development of pH-responsive organic-inorganic hybrid nanocomposites as an effective oral delivery system of protein drugs.
    Lee SH, Song JG, Han HK.
    J Control Release; 2019 Oct 15; 311-312():74-84. PubMed ID: 31487499
    [Abstract] [Full Text] [Related]

  • 12. Development and characterization of HBsAg-loaded Eudragit nanoparticles for effective colonic immunization.
    Sahu KK, Pandey RS.
    Pharm Dev Technol; 2019 Feb 15; 24(2):166-175. PubMed ID: 29468926
    [Abstract] [Full Text] [Related]

  • 13. Pollen grains as a novel microcarrier for oral delivery of proteins.
    Lale SV, Gill HS.
    Int J Pharm; 2018 Dec 01; 552(1-2):352-359. PubMed ID: 30308271
    [Abstract] [Full Text] [Related]

  • 14. Chitosan based nanoparticles as protein carriers for efficient oral antigen delivery.
    Gao P, Xia G, Bao Z, Feng C, Cheng X, Kong M, Liu Y, Chen X.
    Int J Biol Macromol; 2016 Oct 01; 91():716-23. PubMed ID: 27287772
    [Abstract] [Full Text] [Related]

  • 15. Development and physicochemical, toxicity and immunogenicity assessments of recombinant hepatitis B surface antigen (rHBsAg) entrapped in chitosan and mannosylated chitosan nanoparticles: as a novel vaccine delivery system and adjuvant.
    Mehrabi M, Dounighi NM, Rezayat Sorkhabadi SM, Doroud D, Amani A, Khoobi M, Ajdary S, Pilehvar-Soltanahmadi Y.
    Artif Cells Nanomed Biotechnol; 2018 Oct 01; 46(sup1):230-240. PubMed ID: 29260901
    [Abstract] [Full Text] [Related]

  • 16. Lipopolysaccharide derived alginate coated Hepatitis B antigen loaded chitosan nanoparticles for oral mucosal immunization.
    Saraf S, Jain S, Sahoo RN, Mallick S.
    Int J Biol Macromol; 2020 Jul 01; 154():466-476. PubMed ID: 32194106
    [Abstract] [Full Text] [Related]

  • 17. Development and Optimization of Chitosan Nanoparticle-Based Intranasal Vaccine Carrier.
    Gao X, Liu N, Wang Z, Gao J, Zhang H, Li M, Du Y, Gao X, Zheng A.
    Molecules; 2021 Dec 29; 27(1):. PubMed ID: 35011436
    [Abstract] [Full Text] [Related]

  • 18. Preventative vaccine-loaded mannosylated chitosan nanoparticles intended for nasal mucosal delivery enhance immune responses and potent tumor immunity.
    Yao W, Peng Y, Du M, Luo J, Zong L.
    Mol Pharm; 2013 Aug 05; 10(8):2904-14. PubMed ID: 23768205
    [Abstract] [Full Text] [Related]

  • 19. Cationic chitosan-modified silica nanoparticles for oral delivery of protein vaccine.
    Wu X, Farooq MA, Li T, Geng T, Kutoka PT, Wang B.
    J Biomed Mater Res A; 2021 Nov 05; 109(11):2111-2119. PubMed ID: 33871158
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of Eudragit-coated chitosan microparticles as an oral immune delivery system.
    Hori M, Onishi H, Machida Y.
    Int J Pharm; 2005 Jun 13; 297(1-2):223-34. PubMed ID: 15885938
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 21.